cjc-1295 / ipamorelin No DAC + 10mg Ipamorelin blend is Synthesized and Lyophilized in the USA. CJC-1295 & Ipamorelin Blend (10mg)

In September 2023, the FDA further restricted its use by classifying it as a Category 2 bulk drug, effectively barring its inclusion in compounded medications due to concerns about safety, impurities, and insufficient human data [37]

Sidestepping Common Research Errors Over the years, our team has troubleshot just about every reconstitution mistake imaginable

Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: case report

CJC-1295 is a growth hormone releasing hormone (GHRH) analog that stimulates the pituitary gland to release growth hormone, while Ipamorelin is a growth hormone releasing peptide (GHRP) that acts through different pathways to enhance GH secretion